@wombat777 this is likely a better channel for discussion, but based on your valuation of ADN (and exact same table of value) - is it a ballpark estimate to calculate MEP's fair value p/share to be circa $1.47 - counting only for their exposure to ADN tenements?
NOTE: I just assumed a 93% In-Sit Discount based off your 80%/95%/95%
